Editas Medicine to Host Conference Call Discussing Third Quarter 2016 Corporate Update and Results
31 oct. 2016 16h01 HE
|
Editas Medicine
CAMBRIDGE, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on...
Editas Medicine to Present at the Jefferies Gene Editing/Therapy Summit
03 oct. 2016 16h01 HE
|
Editas Medicine
CAMBRIDGE, Mass., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, announced today that it will present at 9:00 a.m. ET and participate in a...
Editas Medicine to Present at the Morgan Stanley Global Healthcare Conference
06 sept. 2016 16h01 HE
|
Editas Medicine
CAMBRIDGE, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present at the Morgan Stanley Global...
Editas Medicine Announces Second Quarter 2016 Results and Update
09 août 2016 16h01 HE
|
Editas Medicine
Exclusive license to high-fidelity Cas9 and Cas9 PAM variants from Massachusetts General Hospital further advances leading genome editing platform Strategic partnership with Adverum to explore...
Editas Medicine to Host Conference Call Discussing Second Quarter 2016 Corporate Update and Results
02 août 2016 16h01 HE
|
Editas Medicine
CAMBRIDGE, Mass., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on...
Editas Medicine to Present at Upcoming June Investor Conferences
24 mai 2016 16h01 HE
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., May 24, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present company overviews at three upcoming...
Editas Medicine Announces First Quarter 2016 Results and Update
16 mai 2016 07h30 HE
|
Editas Medicine, Inc.
Advancing pipeline and platform demonstrated by data presented at medical and scientific conferences as well as achievement of Juno Therapeutics milestone Strengthened effort to develop medicines...
Editas Medicine to Host Conference Call Discussing First Quarter 2016 Corporate Update and Results
09 mai 2016 08h00 HE
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday,...
Editas Medicine Achieves Milestone under its Collaboration with Juno Therapeutics
04 mai 2016 07h30 HE
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, announced today that it has achieved a $2.5 million milestone under its...
Editas Medicine to Present at Deutsche Bank 41st Annual Health Care Conference
27 avr. 2016 08h00 HE
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., April 27, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present a company overview at the Deutsche...